Arizona out to spawn new biotechs

Arizona officials have always talked an ambitious game plan for fostering its fledgling biotech sector. Now a biotechnology incubator and life sciences association in Arizona has launched the ThirdBiotech Research Group, which includes a drug discovery research institute and technology incubator for the promotion of collaborative activities between researchers and industry.

"The group's mission is to form and establish biotech companies based in Arizona by working with collaborative partners, researchers and investors," said Jeff Morhet, CEO of InNexus Biotechnology and founder of ThirdBiotech.

- check out the press release

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.